Resources

Publications

Filter By

05/20/2021
- Tempus-Authored
The TIME Trial Network to Facilitate Rapid Clinical Trial Activation, Patient Screening, and Enrollment in Molecularly Targeted Trials
05/20/2021
- Oncology
- Tempus-Authored
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology (IO) Biomarkers
04/14/2021

Novel Targetable FGFR2 and FGFR3 Alterations in Glioblastoma Associate With Aggressive Phenotype and Distinct Gene Expression Programs
04/13/2021
- Oncology
Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome
04/03/2021
- Tempus-Authored
Early Introductions and Transmission of SARS-CoV-2 Variant B.1.1.7 in the United States
03/17/2021
- Tempus-Authored
Non-secretory Multiple Myeloma With Unusual TFG-ALK Fusion Showed Dramatic Response to ALK Inhibition
03/10/2021
- Tempus-Authored
Transferring Diagnostic and Prognostic Molecular Models Across Technological Platforms
03/10/2021
- Tempus-Authored
Incidence of Molecular Alterations in KRAS and Other Known Cancer Genes in Patients With Pancreatic Cancer Assessed With a Commercial Genomic Profiling Panel Compared to TCGA Results
03/10/2021
- Tempus-Authored
Characterizing Differences in Checkpoint Inhibitor Biomarkers in a Real-world Cohort of Stage III and IV Non-small Cell Lung Cancer Patients
03/10/2021
- Oncology
- Tempus-Authored
Genomic Characterization and Monitoring Molecular Response to Treatment in African American (AA) Advanced Prostate Cancer (PC) Patients (Pts) via Next-Generation Sequencing (NGS): Real-world Experience in a Safety Net Hospital Oncology Clinic

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16